Remote Patient Monitoring with CapMedic

reimbursable by RPM, RTM and CCM codes

Track Objective data  |  Assess Patient input  |  Provide early intervention

CapMedic® is an FDA-cleared Class II patented medical device. It captures physiologic measures of lung function and inhalation parameters.

Track trends in lung function data.

1. Remotely and objectively understand disease control

Capture repeatable daily lung function

  • Audio feedback encourages full patient effort
  • <3s test, no app to connect leads to high compliance
  • No moving parts/fan leads to best-in-class repeatability

Instant traffic light Assessment

NHLBI traffic-light comparison with personal best.

  • Optional app shows patients their lung function trends
  • RPM, CCM codes apply

Track trends in lung function data.

No-forced breathing airway obstruction capture

PulmoScan oscillometry device measures airway obstruction

  • For young children and elderly
  • For patients where early trends are critical
  • Based on lung oscillometry
  • The only FDA-cleared home-use device

Simple 3-Color Assessment

NHLBI traffic-light comparison with personal best.

  • Instant assessment using a quick Red-Yellow-Green traffic-light showing comparison with personal best.
  • Optional app shows FEV1 and PEF values for tracking.
  • RPM, CCM codes apply

2. Aid correct inhaler use

Smartinhaler gives verbal-visual feedback for correct use

  • Track medication use – Improve inhaler use beyond tracking doses
  • Vocally coaches for correct inhaler use
  • Date, time of puff
  • Inhaler shaking
  • Angle (orientation)
  • Coordination
  • Duration of active inhalation flow
  • Breath-hold

3X improvement in inhaler technique*

*Data from Paronyan et al. ’20, Landon et al. ’20

  • Set medication reminders
  • Placebo inhalers for in-clinic training (reimbursable)
  • Both RTM, RPM codes apply

3. Monitoring and care coordination

Cognita's team of trained care coordinators aid monitoring, timely intervention and billing

  • Our care coordinator will communicate with the patient regularly and keep track of declining lung function or symptoms.
  • Monitoring and reporting services for reimbursement from RPM, RTM, and CCM codes.

Track at-risk patients in your clinic

Provide care using objective patient data

Increase patient engagement and satisfaction.

Dynamic, intuitive visualization of all the data

GINA guidelines recommend a 2-month visualization of FEV1, PEF to allow accurate identification of worsening asthma.

Summary charts to simplify the data than looking at numbers.

Simple RPM setup with remote onboarding

Easy Setup and
Onboarding

Cognita provides remote installation and onboarding including:

  • Teach correct, effortful PFT technique
  • Train proper inhaler use
 

RPM code 99453 ~$20

Automated Data Transmission

Patients perform PFTs, get daily feedback on inhaler use.

Automatical data sync over wifi/cellular network.

RPM code 99454 ~$74/mo

Care Coordination
Early Intervention

Cognita’s care team also performs:

  • Weekly review of data and patient check-ins
  • Care coordination with physicians for medical interventions

RPM code 99457 ~$56/mo
+ 99458 ~$45/mo

RPM code 99453 ~$20

RPM code 99454 ~$74/mo

RPM code 99457 ~$56/mo
+ 99458 ~$45/mo

See a demo of the full solution

See a live demo of the full RPM solution with CapMedic and implementation workflow for your practice. Fill the form out below and we will get in touch with you at your preferred time. Don’t worry, we don’t spam and you can unsubscribe at any time.

© 2022 Cognita Labs, LLC All Rights Reserved. CapMedic is a registered trademark of Cognita Labs, LLC. 700 N Main St. Ste C1 Santa Ana CA 92701

VENTOLIN®, ADVAIR®, and FLOVENT® are registered trademarks of the GSK group of companies. PROVENTIL®, ASMANEX®, and DULERA® are registered trademarks of Merck Sharp & Dohme Corp. Endo International plc. PROAIR® is a registered trademark of Teva Respiratory, LLC. ALVESCO® is a registered trademark of Takeda GmbH. XOPENEX® is a registered trademark of Sunovion Pharmaceuticals Inc. ATROVENT® is a trademark of Boehringer Ingelheim International GmbH. SYMBICORT® is a trademark of AstraZeneca AB.